Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
UI Schwarz - European journal of clinical investigation, 2003 - Wiley Online Library
Abstract Cytochrome P450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical
use. Of special interest are those with a narrow therapeutic index, such as S‐warfarin …
use. Of special interest are those with a narrow therapeutic index, such as S‐warfarin …
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
UI Schwarz - European Journal of Clinical Investigation, 2003 - search.ebscohost.com
Abstract Cytochrome P450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical
use. Of special interest are those with a narrow therapeutic index, such as S-warfarin …
use. Of special interest are those with a narrow therapeutic index, such as S-warfarin …
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
UI Schwarz - European journal of clinical investigation, 2003 - pubmed.ncbi.nlm.nih.gov
Cytochrome p450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical use. Of
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
[引用][C] Clinical relevance of genetic polymorphisms in the humanCYP2C9gene
UI Schwarz - European Journal of Clinical Investigation, 2003 - cir.nii.ac.jp
Clinical relevance of genetic polymorphisms in the humanCYP2C9gene | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
UI Schwarz - European Journal of Clinical Investigation, Supplement, 2003 - elibrary.ru
Cytochrome P450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical use. Of
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
UI Schwarz - European Journal of Clinical Investigation, 2003 - europepmc.org
Cytochrome p450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical use. Of
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
special interest are those with a narrow therapeutic index, such as S-warfarin, tolbutamide …
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
UI Schwarz - European Journal of Clinical Investigation, 2003 - search.ebscohost.com
Abstract Cytochrome P450 (CYP) 2C9 hydroxylates about 16% of drugs in current clinical
use. Of special interest are those with a narrow therapeutic index, such as S-warfarin …
use. Of special interest are those with a narrow therapeutic index, such as S-warfarin …
[引用][C] Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
S UI - Eur J Clin Invest, 2003 - cir.nii.ac.jp
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …